FFR Versus Angiography-Guided Strategy for Management of AMI With Multivessel Disease

NACompletedINTERVENTIONAL
Enrollment

1,292

Participants

Timeline

Start Date

August 19, 2016

Primary Completion Date

June 30, 2022

Study Completion Date

December 31, 2023

Conditions
Acute Myocardial Infarction
Interventions
DEVICE

PCI using 2nd generation drug-eluting stent

"Percutaneous coronary intervention (PCI) using 2nd generation drug-eluting stent for non-IRA stenosis will be decided according to the allocated arms.~1. FFR-guided strategy arm~2. Angiography-guided strategy arm"

Trial Locations (1)

Unknown

Samsung Medical Center, Seoul

All Listed Sponsors
collaborator

Seoul National University Hospital

OTHER

collaborator

Inje University

OTHER

collaborator

Keimyung University Dongsan Medical Center

OTHER

collaborator

Sejong General Hospital

OTHER

collaborator

Wonju Severance Christian Hospital

OTHER

collaborator

Chungbuk National University Hospital

OTHER

collaborator

Chosun University Hospital

OTHER

collaborator

Inha University Hospital

OTHER

collaborator

Gyeongsang National University Hospital

OTHER

collaborator

KangWon National University Hospital

OTHER

collaborator

Incheon St.Mary's Hospital

OTHER

collaborator

Uijeongbu St. Mary Hospital

OTHER

collaborator

Ajou University School of Medicine

OTHER

collaborator

Chonnam National University Hospital

OTHER

collaborator

Kosin University Gospel Hospital

OTHER

collaborator

Samsung Changwon Hospital

OTHER

collaborator

Kangbuk Samsung Hospital

OTHER

collaborator

Yeungnam University Hospital

OTHER

lead

Samsung Medical Center

OTHER

NCT02715518 - FFR Versus Angiography-Guided Strategy for Management of AMI With Multivessel Disease | Biotech Hunter | Biotech Hunter